Osteoarthritis Trial, Recruiting NCT04031820 Sponsor: JointResearch Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT04031820
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are scheduled for a planned (non-emergency) first-time hip replacement surgery using a cemented cup with a specific size liner (32mm or 36mm), for any medical reason
  • People whose hip replacement surgery will be performed using a specific surgical technique called the posterolateral approach (confirm with trial site if unsure which approach is planned)
  • People aged 70 years or older
  • People who can read and understand written and spoken Dutch

Who may not be able to join:

  • People who are unable to complete patient questionnaires about their own health and experience
  • People who have dementia, epilepsy, spasticity, intellectual disability, or alcoholism
  • People whose medical situation means they are not suitable for either of the two specific cup types used in this trial (a unipolar cup or a dual mobility cup) — these people may instead be invited to take part in a separate observational study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rudolf Poolman, MD, PhD, OLVG, Amsterdam, the Netherlands

Phone: +31205993653

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
JointResearch
Registry
ClinicalTrials.gov
Start date
1 January 2019
Est. completion
1 May 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Number of dislocations

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov